Markets:

Overview

News

Currencies

International

Treasuries

Corner Growth Acquisition Corp. - Class A Ordinary Shares (NQ:COOL)

11.10 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 24, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Corner Growth Acquisition Corp. - Class A Ordinary Shares

< Previous 1 2 Next >

How Bad Are PolarityTE's Earnings? | Return On Capital Employed ↗

September 30, 2021

PolarityTE (NASDAQ:PTE) brought in sales totaling $2.54 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 5.1%, resulting in a loss of $8....

Via Benzinga

PolarityTE, Inc. (NASDAQ:PTE) Investor Alert: Investigation over Possible Violations of Securities Laws ↗

September 09, 2021

San Diego, CA -- (SBWIRE) -- 09/09/2021 -- An investigation over potential securities laws violations by PolarityTE, Inc. in connection with certain financial statements was announced.

Via SBWire

PolarityTE Stock Drops On FDA Clinical Hold On SkinTE Trial Application ↗

August 24, 2021

The FDA has issued a clinical hold on PolarityTE Inc's (NASDAQ: PTE) SkinTE Investigational New Drug Application (IND) for chronic cutaneous ulcers. The...

Via Benzinga

PTE Stock: The FDA News That Has Biotech Penny Stock PolarityTE Plunging Today ↗

August 24, 2021

PolarityTE (PTE) stock is taking a beating on Tuesday after the biotechnology company got an update from the FDA on its IND.

Via InvestorPlace

PolarityTE's SkinTE Meets Primary, Secondary Endpoint Goals In Diabetic Foot Ulcer Trial ↗

July 28, 2021

PolarityTE Inc (NASDAQ: PTE) has announced final data from a trial evaluating SkinTE plus standard of care (SOC) vs. SOC alone for Diabetic Foot Ulcers. The trial...

Via Benzinga

PolarityTE Stock Drops On Wider Than Expected Q1 Loss, SkinTE Transitions To BLA Pathway ↗

May 14, 2021

PolarityTE Inc (NASDAQ: PTE) reported a Q1 EPS loss of $(0.24), missing the consensus of $(0.12) loss, but better than $(0.39) loss a year ago. Sales of $...

Via Benzinga

Why PolarityTE Shares Are Trading Higher On Monday ↗

May 10, 2021

PolarityTE (NASDAQ: PTE) shares are trading higher after the company announced its Diabetic Foot Ulcers trial met its primary and secondary endpoints. In the company's multi-...

Via Benzinga

PolarityTE Stock Jumps As SkinTE Aces Diabetic Foot Ulcer Trial ↗

May 10, 2021

PolarityTE Inc (NASDAQ: PTE) has announced preliminary topline data from a multi-center randomized controlled trial evaluating SkinTE for the...

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.